🔗 Share this article

Acclaimed soul vocalist D’Angelo died on October 14 at 51 years old after a private battle with pancreatic cancer.

“The shining star of our household has dimmed his light for us in the present world,” his relatives stated. “After a lengthy and brave struggle with the disease, we are deeply saddened to declare that Michael D’Angelo Archer, recognized by his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on the music industry with his pioneering neo-soul sound and partnerships with high-profile artists.

He launched his debut album, “Brown Sugar,” in the mid-nineties to immediate acclaim. The record reached the fourth spot on the R&B charts, went platinum soon after, and earned multiple Grammy nominations.

However, it was his second album, “Voodoo,” in 2000 that boosted his music career into the limelight. The album debuted at No. 1 on each of the R&B charts and the main album chart. He received two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a hesitant one, in the public consciousness. The intimate portrayal featured the artist, famously bare to his midsection, singing directly into the camera.

D’Angelo stepped back from the public eye after putting out Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a serious car crash that left him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with another top chart entry on the R&B chart and a Grammy for Top R&B Record.

Once more, in his own enigmatic way, D’Angelo made only a few public outings in the following years.

The musician was scheduled as a headliner for the 2025 music event, but his appearance was called off, due to an “unexpected health issue.”

Even though information is limited about D’Angelo’s health in the weeks before his death, he had reportedly been in the hospital for months and in hospice for a fortnight.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic cancer, one of the deadliest and hardest to prevent types of the illness, on a gifted artist whose existence was ended too soon.

“We are grieved that he can only provide dear memories with his loved ones, but we are forever thankful for the legacy of extraordinarily moving songs he leaves behind,” his family expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic cancer affects the pancreas, a tiny gland that generates insulin and plays an essential role in digestion, among additional roles. The position and dimensions of the organ in the body make it more difficult to identify malignancy.

Although this cancer makes up only about 3% of cancer diagnoses each year in the U.S., it is responsible for 7% of malignancy fatalities.

Almost 70,000 people will be found to have pancreatic cancer and roughly fifty-two thousand will die of the illness in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have limited and poor treatment options, and a narrow opportunity to make a significant difference on the well-being of patients,” said a cancer specialist.

Since this disease rarely causes early symptoms, it’s often identified only once the disease is late-stage. Although a patient has symptoms they are often nonspecific and may be mistaken for a several everyday ailments.

“Currently, there is no good way to identify this malignancy in the early stages, except for paying attention to physical changes and speaking with your physician if there are new or unusual symptoms,” explained a health expert.

Common symptoms of this disease include:

• discomfort in the stomach or back
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• nausea

At age 51, D’Angelo’s death is an exception, as this malignancy is typically found in individuals in the sixty-five to seventy-five range. However, many cancers, such as this type, have become increasingly prevalent in younger people.

“This disease identified before the age of 50 is considered uncommon, yet alarmingly, clinicians are beginning to see a rising count of younger patients suffering from this condition,” said a specialist.

Family History Impacts Disease Probability

Without effective screening tools for pancreatic cancer, experts stressed the significance of knowing your family’s health background. Some risk factors, such as tobacco use and obesity also play a role in the onset of this disease.

Black individuals have the highest incidence of this malignancy in the United States and are more prone to be found to have untreatable disease.

“The initial action toward lowering one’s risk of pancreatic cancer is assessing individual susceptibility. People should review their family history, genetic background, and medical conditions, such as diabetes, chronic pancreatitis, or obesity that may increase their susceptibility,” advised a specialist.

Hereditary risk factors are associated with as much as ten percent of all this malignancy cases. If a relative in your family has had pancreatic cancer, you may want to consider genetic testing.

“For individuals with a relative’s background of pancreatic cancer or those having elevated risk genetic mutations, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to find early changes in the pancreas,” he explained.

For those wishing to lower their chance, lifestyle changes may make a difference. The best action you can take to lower your risk of this disease is to quit smoking, and if you are a non-smoker, stay away altogether.

Excessive alcohol consumption is linked to pancreatitis, a risk factor for this malignancy, so reducing or abstaining from alcohol may help reduce your risk.

Managing your body mass or shedding pounds may also help decrease your susceptibility. Individuals with obesity are 20% more likely to develop pancreatic cancer. Pancreatic cancer also occurs more often in people with blood sugar issues, and reducing weight can also lower the risk of type 2 diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and more recent combination chemotherapy. There are emerging targeted therapies that are already making an impact,” remarked a expert.

For many individuals, however, awareness about this rare but {dev